Trials / Terminated
TerminatedNCT05703464
Elobixibat for Chronic Constipation Without Defecation Desire
A Multicenter, Single-group, Open-label, Before-and-after Study Confirming Recovery of Defecation Desire by Administration of Elobixibat in Patients With Chronic Constipation
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- International University of Health and Welfare · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Patients of chronic constipation without defecation desire will be orally administered elobixibat 10 mg once daily before meals for 4 weeks. The primary endpoint of the pre/post comparative study will be the percentage of improvement in bowel movements from Week 2 of the observation period at Week 4 of the treatment period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Elobixibat 10mg | Patients of chronic constipation with loss of defecation desire are administered Elobixibat 10mg for 4 weeks |
Timeline
- Start date
- 2023-02-09
- Primary completion
- 2023-03-03
- Completion
- 2023-03-03
- First posted
- 2023-01-30
- Last updated
- 2023-03-09
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT05703464. Inclusion in this directory is not an endorsement.